Casting a shadow on liver X receptor-mediated atheroprotection: is LXRβ to blame?

Authors


Antonio Moschetta, MD PhD, Department of Translational Pharmacology, Consorzio Mario Negri Sud, Via Nazionale 8/A, 66030 Santa Maria Imbaro (CH), Italy. (fax: +39-0872570299; e-mail: moschetta@negrisud.it).

No abstract is available for this article.

Ancillary